1
|
Lv JF, Tan YF, Zhao YN, Yang D, He YH, Guan Z. Electrochemical C(sp 2)-H/N-H "formal" cross-dehydrogenative coupling of olefins with benzotriazoles for synthesis of N-vinyl benzotriazoles. Org Biomol Chem 2023; 21:8488-8493. [PMID: 37855422 DOI: 10.1039/d3ob01300f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2023]
Abstract
The paper details an electrochemical method that couples olefins with benzotriazoles to form C(sp2)-N bonds, enabling the synthesis of N-vinyl benzotriazoles in moderate to good yields. nBu4NI functions as both an electrolyte and an iodine mediator, and the method does not require oxidants or metals. It is a highly atom-economical and clean reaction, with hydrogen as the sole byproduct.
Collapse
Affiliation(s)
- Jin-Feng Lv
- Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
| | - Yu-Fang Tan
- Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
| | - Ya-Nan Zhao
- Analytical and Testing Center, Southwest University, Chongqing, 400715, China
| | - Dan Yang
- Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
| | - Yan-Hong He
- Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
| | - Zhi Guan
- Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
| |
Collapse
|
7
|
Giroux S, Xu J, Reddy TJ, Morris M, Cottrell KM, Cadilhac C, Henderson JA, Nicolas O, Bilimoria D, Denis F, Mani N, Ewing N, Shawgo R, L’Heureux L, Selliah S, Chan L, Chauret N, Berlioz-Seux F, Namchuk MN, Grillot AL, Bennani YL, Das SK, Maxwell JP. Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b Inhibitors. ACS Med Chem Lett 2014; 5:240-3. [PMID: 24900811 DOI: 10.1021/ml300461f] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2012] [Accepted: 01/27/2013] [Indexed: 12/17/2022] Open
Abstract
The discovery of potent thienoimidazole-based HCV NS5A inhibitors is herein reported. A novel method to access the thienoimidazole [5,5]-bicyclic system is disclosed. This method gave access to a common key intermediate (6) that was engaged in Suzuki or Sonogashira reactions with coupling partners bearing different linkers. A detailed study of the structure-activity relationship (SAR) of the linkers revealed that aromatic linkers with linear topologies are required to achieve high potency for both 1a and 1b HCV genotypes. Compound 20, with a para-phenyl linker, was identified as a potential lead displaying potencies of 17 and 8 pM against genotype 1a and 1b replicons, respectively.
Collapse
Affiliation(s)
- Simon Giroux
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Jinwang Xu
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - T. Jagadeeswar Reddy
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Mark Morris
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Kevin M. Cottrell
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Caroline Cadilhac
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - James A. Henderson
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Oliver Nicolas
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Darius Bilimoria
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Francois Denis
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Nagraj Mani
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Nigel Ewing
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Rebecca Shawgo
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Lucille L’Heureux
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Subajini Selliah
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Laval Chan
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Nathalie Chauret
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Francoise Berlioz-Seux
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Mark N. Namchuk
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Anne-Laure Grillot
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| | - Youssef L. Bennani
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - Sanjoy K. Das
- Vertex Pharmaceuticals Canada Incorporated, 275 Boul. Armand-Frappier, Laval,
QC, H7V 4A7, Canada
| | - John P. Maxwell
- Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts
02139, United States
| |
Collapse
|
12
|
Li H, Boonnak N, Padwa A. N-Alkenyl Indoles as Useful Intermediates for Alkaloid Synthesis. J Org Chem 2011; 76:9488-96. [PMID: 22007631 DOI: 10.1021/jo201955c] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Hao Li
- Department
of Chemistry, Emory University, Atlanta,
Georgia 30322, United States
| | - Nawong Boonnak
- Department
of Chemistry, Emory University, Atlanta,
Georgia 30322, United States
| | - Albert Padwa
- Department
of Chemistry, Emory University, Atlanta,
Georgia 30322, United States
| |
Collapse
|
18
|
Taillefer M, Ouali A, Renard B, Spindler JF. Mild Copper-Catalyzed Vinylation Reactions of Azoles and Phenols with Vinyl Bromides. Chemistry 2006; 12:5301-13. [PMID: 16680787 DOI: 10.1002/chem.200501411] [Citation(s) in RCA: 107] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
An efficient and straightforward copper-catalyzed method allowing vinylation of N- or O-nucleophiles with di- or trisubstituted vinyl bromides is reported. The procedure is applicable to a broad range of substrates since N-vinylation of mono-, di-, and triazoles as well as O-vinylation of phenol derivatives can be performed with catalytic amounts of copper iodide and inexpensive nitrogen ligands 3 or 8. In the case of more hindered vinyl bromides, the use of the original bidentate chelator 8 was shown to be more efficient to promote the coupling reactions than our key tetradentate ligand 3. The corresponding N-(1-alkenyl)azoles and alkenyl aryl ethers are obtained in high yields and selectivities under very mild temperature conditions (35-110 degrees C for N-vinylation reactions and 50-80 degrees C for O-vinylation reactions). Moreover, to our knowledge, this method is the first example of a copper-catalyzed vinylation of various azoles. Finally, this protocol, practical on a laboratory scale and easily adaptable to an industrial scale, is very competitive compared to the existing methods that allow the synthesis of such compounds.
Collapse
Affiliation(s)
- Marc Taillefer
- CNRS UMR 5076, Hétérochimie moléculaire et macromoléculaire Ecole Nationale Supérieure de Chimie de Montpellier, 8 rue de l'Ecole Normale, 34296 Montpellier Cedex 5, France.
| | | | | | | |
Collapse
|
22
|
Seley KL, Januszczyk P, Hagos A, Zhang L, Dransfield DT. Synthesis and antitumor activity of thieno-separated tricyclic purines. J Med Chem 2000; 43:4877-83. [PMID: 11123997 DOI: 10.1021/jm000326i] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The purine ring system is undoubtedly one of the most ubiquitous heterocyclic ring systems in nature as it has the distinction of being the parent ring in countless derivatives of biological relevance. It is not surprising then that modified purines possess the potential to impact several areas, including a better understanding of the biological effects of DNA damaging agents, enzyme/substrate interactions, and in the development of more potent medicinal agents. One focus for our research at Georgia Tech has centered around the design and synthesis of a series of extended purine analogues containing a heterocyclic spacer ring, with sites set on investigations into their use as (i) potential anticancer and antiviral agents, (ii) dimensional probes for enzyme and coenzyme binding sites, and (iii) structural probes of the minor groove of DNA. The synthesis and preliminary antitumor activity of two thieno-separated purine analogues are described herein. Tricyclic 1 was synthesized in 12 steps from tribromoimidazole and with an overall yield of 7%. Tricyclic 2 was synthesized in 9 steps with an overall yield of 13%. Both 1 and 2 exhibited growth inhibitory effects on HCT116 colorectal cancer cells in vitro.
Collapse
Affiliation(s)
- K L Seley
- Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia 30912, USA.
| | | | | | | | | |
Collapse
|